Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Older Adults
100%
Combined Modality Therapy
100%
Nasopharyngeal Carcinoma
100%
Prospective multicenter Study
100%
Interferon-beta (IFN-β)
100%
Neoadjuvant Chemotherapy
50%
Cisplatin
33%
Distant Metastasis
33%
Complete Remission
33%
Irradiation
33%
Stage III-IV
33%
Pediatric Oncology
16%
Radiotherapy
16%
Treatment Completion
16%
Survival Rate
16%
Event-free Survival
16%
Overall Survival
16%
Children's Oncology Group
16%
Hearing Impairment
16%
Mucositis
16%
Radiation Dose
16%
Pediatric Hematology
16%
Folinic Acid
16%
Maintenance Treatment
16%
Magnetic Resonance Imaging Study
16%
Nausea
16%
Late Toxicity
16%
Chemoradiotherapy
16%
Hypothyroidism
16%
Tumor Response
16%
Partial Response
16%
First Week
16%
Leukopenia
16%
American Cancer Society
16%
Acute Toxicity
16%
5-fluorouracil (5-FU)
16%
Local Progression
16%
Diagnostic Imaging
16%
Combined Therapy
16%
Published Results
16%
Stage II Nasopharyngeal Carcinoma
16%
German Society
16%
Pelvic Bone Metastases
16%
Pediatric Nasopharyngeal Carcinoma
16%
DCog
16%
Well Tolerated
16%
Positron Emission Tomography Scan
16%
Good Outcome
16%
Medicine and Dentistry
Nasopharynx Carcinoma
100%
Beta Interferon
100%
Neoadjuvant Chemotherapy
37%
Cisplatin
25%
Distant Metastasis
25%
Diseases
25%
Malignant Neoplasm
12%
Neoplasm
12%
Childhood Cancer
12%
Pediatrics
12%
Oncology
12%
Event Free Survival
12%
Survival Rate
12%
Overall Survival
12%
Magnetic Resonance Imaging
12%
Positron Emission Tomography
12%
Mucositis
12%
Maintenance Therapy
12%
Hearing Impairment
12%
Hypothyroidism
12%
Nausea
12%
Pediatric Hematology
12%
Bone Metastasis
12%
Chemoradiotherapy
12%
Leukopenia
12%
Fluorouracil
12%
Diagnostic Imaging
12%
Combined Therapy
12%
Folinic Acid
12%
Acute Toxicity
12%
Radiation Therapy
12%
pelvic bones
12%
Median Follow Up
12%